JOSHUA MAKOWER
CIK 1235952 · last filed 2022-10-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$678.52M
Companies
18
Total Filings
46
Lifetime Open-Market Net
$218.01M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Eargo, Inc. (EAR) Delisted | Director | 1,500 | $2.57 | $3.9K | $5.60M | 5 | 2022-10-14 |
| NeueHealth, Inc. (BHG) Delisted | 10%+ Owner | 278,608 | $16.35 | $4.56M | $35.00M | 1 | 2021-06-30 |
| GLUE | 10%+ Owner | 5,973,296 | $22.04 | $131.65M | $19.95M | 1 | 2021-06-30 |
| Desktop Metal, Inc. (DM) Delisted | 10%+ Owner | 228 | $4.96 | $1.1K | $0 | 1 | 2021-06-10 |
| MRKR | 10%+ Owner | 1,071,428 | $1.18 | $1.26M | $10.00M | 1 | 2021-03-18 |
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 645,106 | $8.16 | $5.26M | $3.96M | 3 | 2020-12-07 |
| Metacrine, Inc. (MTCR) Delisted | 10%+ Owner | 1,958,333 | $0.49 | $969.2K | $10.00M | 1 | 2020-09-22 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 2,000,533 | $4.00 | $8.00M | $4.00M | 1 | 2020-07-28 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | 10%+ Owner | 10,376,936 | $0.00 | $6.2K | $21.78M | 3 | 2020-07-28 |
| NKTX | 10%+ Owner | 522,639 | $2.22 | $1.16M | $12.00M | 1 | 2020-07-16 |
| Akouos, Inc. (AKUS) Delisted | 10%+ Owner | 513,758 | $13.29 | $6.83M | $10.00M | 1 | 2020-07-01 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 3,952,958 | $15.00 | $59.29M | $24.62M | 16 | 2020-06-22 |
| TRVI | 10%+ Owner | 5,938,562 | $18.43 | $109.45M | $25.00M | 2 | 2020-04-13 |
| ARDX | 10%+ Owner | 3,082,186 | $5.08 | $15.67M | $23.33M | 4 | 2019-12-09 |
| MIRM | 10%+ Owner | 3,736,243 | $112.23 | $419.32M | $6.75M | 1 | 2019-07-24 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | 10%+ Owner | 0 | $28.80 | $0 | -$731.3K | 1 | 2018-02-27 |
| Cascadian Therapeutics, Inc. (CASC) Delisted | 10%+ Owner | 10,882,574 | — | — | $0 | 1 | 2018-02-22 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 5,215,128 | — | — | $6.75M | 1 | 2016-12-19 |
Recent Filings · Page 3 of 5
46 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-25 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Buy (P) | +2,857,142 | $10.00M | EDGAR |
| 2019-05-13 | TRVI | Mixed | +4,438,562 | $25.00M | EDGAR |
| 2019-05-09 | Regulus Therapeutics Inc. (RGLS) Delisted | Buy (P) | +1,136,704 | $1.23M | EDGAR |
| 2019-04-08 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +4,347,827 | $4.96M | EDGAR |
| 2019-02-19 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Buy (P) | +9,948,269 | $4.69M | EDGAR |
| 2018-12-21 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +500,000 | $774.4K | EDGAR |
| 2018-12-12 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +61,200 | $121.1K | EDGAR |
| 2018-12-10 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +170,400 | $338.4K | EDGAR |
| 2018-11-30 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +96,400 | $190.9K | EDGAR |
| 2018-11-21 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +170,000 | $336.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.